Shauna Blois, DVM, DVSc, DACVIM (SAIM)
Director

Dr. Shauna Blois is an Assistant Professor and Section Head in the Small Animal Internal Medicine Service at the Ontario Veterinary College. She attended Mount Allison University where she earned a Bachelor of Science with Honours, then completed a Doctor of Veterinary Medicine degree at the Atlantic Veterinary College in Prince Edward Island. Upon graduation from veterinary school in 2004, Dr. Blois pursued a rotating internship in small animal medicine and surgery at the University of Guelph. She was then accepted into the Doctor of Veterinary Science and clinical residency training program in small animal internal medicine at the University of Guelph. Her dissertation work examined the canine platelet function and prostaglandin expression in the presence of various anti-inflammatory agents. Dr. Blois became certified by the American College of Veterinary Internal Medicine (ACVIM) in Small Animal Internal Medicine in 2008. After completion of this program, she joined the Small Animal Internal Medicine team at the University of Guelph. Dr. Blois is also active in the American College of Veterinary Internal Medicine, serving as a Small Animal Internal Medicine Representative on the Advanced Continuing Education Committee as well as a member of the Nominating Committee. Dr. Blois’s research examines: (1) the biology of platelets and hemostatic proteins in health and disease, and (2) investigating the intersection of hemostasis and inflammation in various diseases including immune mediated hemolytic anemia. Recent and present studies investigate novel methods of measuring hemostasis in inflammatory disorders, the roles of cytokines including interleukin-17 in the pathophysiology of immune mediated disease, the gastrointestinal microbiome in states of health and inflammation, and the role of platelet leukocyte aggregates under normal and inflammatory conditions. The overall goal of her research program is to further understand the role of the hemostatic system in immune responses in states of health and disease. (Board term ends 2026)